Cargando…
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302951/ https://www.ncbi.nlm.nih.gov/pubmed/30412228 http://dx.doi.org/10.1093/ecco-jcc/jjy135 |
| _version_ | 1783382083099426816 |
|---|---|
| author | Panés, Julian Vermeire, Séverine Lindsay, James O Sands, Bruce E Su, Chinyu Friedman, Gary Zhang, Haiying Yarlas, Aaron Bayliss, Martha Maher, Stephen Cappelleri, Joseph C Bushmakin, Andrew G Rubin, David T |
| author_facet | Panés, Julian Vermeire, Séverine Lindsay, James O Sands, Bruce E Su, Chinyu Friedman, Gary Zhang, Haiying Yarlas, Aaron Bayliss, Martha Maher, Stephen Cappelleri, Joseph C Bushmakin, Andrew G Rubin, David T |
| author_sort | Panés, Julian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6302951 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63029512018-12-27 Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies Panés, Julian Vermeire, Séverine Lindsay, James O Sands, Bruce E Su, Chinyu Friedman, Gary Zhang, Haiying Yarlas, Aaron Bayliss, Martha Maher, Stephen Cappelleri, Joseph C Bushmakin, Andrew G Rubin, David T J Crohns Colitis Corrigendum Oxford University Press 2019-01 2018-11-08 /pmc/articles/PMC6302951/ /pubmed/30412228 http://dx.doi.org/10.1093/ecco-jcc/jjy135 Text en © European Crohn’s and Colitis Organisation (ECCO) 2018. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrigendum Panés, Julian Vermeire, Séverine Lindsay, James O Sands, Bruce E Su, Chinyu Friedman, Gary Zhang, Haiying Yarlas, Aaron Bayliss, Martha Maher, Stephen Cappelleri, Joseph C Bushmakin, Andrew G Rubin, David T Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| title | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| title_full | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| title_fullStr | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| title_full_unstemmed | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| title_short | Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies |
| title_sort | tofacitinib in patients with ulcerative colitis: health-related quality of life in phase 3 randomised controlled induction and maintenance studies |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302951/ https://www.ncbi.nlm.nih.gov/pubmed/30412228 http://dx.doi.org/10.1093/ecco-jcc/jjy135 |
| work_keys_str_mv | AT panesjulian tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT vermeireseverine tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT lindsayjameso tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT sandsbrucee tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT suchinyu tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT friedmangary tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT zhanghaiying tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT yarlasaaron tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT baylissmartha tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT maherstephen tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT cappellerijosephc tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT bushmakinandrewg tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies AT rubindavidt tofacitinibinpatientswithulcerativecolitishealthrelatedqualityoflifeinphase3randomisedcontrolledinductionandmaintenancestudies |